Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements Of Shareholders' Equity

v3.22.1
Consolidated Statements Of Shareholders' Equity - USD ($)
$ in Thousands
Total
Business Combination Successor Entity
Common Stock
Common Stock
Business Combination Successor Entity
Additional Paid-in Capital
Additional Paid-in Capital
Business Combination Successor Entity
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Business Combination Successor Entity
Beginning balance (in shares) at Dec. 31, 2018     53,045,510            
Beginning balance at Dec. 31, 2018 $ 314,641   $ 53,046   $ 299,204   $ (7,603) $ (30,006)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shareholders' capital distributions (12,360)       (12,360)        
Capital issued in Ironman Acquisition 2,500       2,500        
Net (loss) income (42,037)             (42,037)  
Other comprehensive income (loss) (358)           (358)    
Ending balance (in shares) at Dec. 31, 2019     53,045,510            
Ending balance at Dec. 31, 2019 262,386   $ 53,046   289,344   (7,961) (72,043)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 24,249             24,249  
Other comprehensive income (loss) $ 4,787           4,787    
Ending balance (in shares) at Dec. 31, 2020 53,045,510   53,045,510            
Ending balance at Dec. 31, 2020 $ 291,422   $ 53,046   289,344   (3,174) (47,794)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shareholders' capital distributions (60,000)       (60,000)        
Share-based compensation 156       156        
Net (loss) income 20,629             20,629  
Other comprehensive income (loss) 236           236    
Ending balance (in shares) at Nov. 08, 2021     53,045,510 156,937,410          
Ending balance at Nov. 08, 2021 $ 252,443 $ 1,476,881 $ 53,046 $ 156,937 229,500 $ 1,376,312 (2,938) (27,165) $ (56,368)
Beginning balance (in shares) at Dec. 31, 2020 53,045,510   53,045,510            
Beginning balance at Dec. 31, 2020 $ 291,422   $ 53,046   289,344   (3,174) (47,794)  
Ending balance (in shares) at Dec. 31, 2021 157,237,435   157,237,435            
Ending balance at Dec. 31, 2021 $ 1,083,310   $ 157,237   1,670,033   (7,135) (736,825)  
Beginning balance (in shares) at Nov. 08, 2021     53,045,510 156,937,410          
Beginning balance at Nov. 08, 2021 252,443 $ 1,476,881 $ 53,046 $ 156,937 229,500 $ 1,376,312 (2,938) (27,165) $ (56,368)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation 290,846       290,846        
Sale of PSSA Ordinary Shares issued to Director Subscribers (in shares)     200,000            
Sale of PSSA Ordinary Shares issued to Director Subscribers 2,000   $ 200   1,800        
Ordinary shares issued related to share-based compensation (in shares)     100,000            
Ordinary shares issued related to share-based compensation 1,175   $ 100   1,075        
Exercise of warrants (in shares)     25            
Net (loss) income (680,457)             (680,457)  
Other comprehensive income (loss) $ (7,135)           (7,135)    
Ending balance (in shares) at Dec. 31, 2021 157,237,435   157,237,435            
Ending balance at Dec. 31, 2021 $ 1,083,310   $ 157,237   $ 1,670,033   $ (7,135) $ (736,825)